mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.04 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.04 |
mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.04 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.04 |
mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.04 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.04 |
mRNA |
BRD-K33514849 |
CTRPv2 |
pan-cancer |
AAC |
-0.26 |
0.04 |
mRNA |
VU0155056 |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.04 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.04 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.04 |